Opioid Settlement Fund and Advisory Council; bring forward sections creating.

HB 1760 organizes Mississippi's management of opioid settlement funds from lawsuits against drug companies (like Purdue Pharma and Walgreens). It creates two fund categories: "abatement" funds (for opioid treatment programs, requiring council recommendations) and "nonabatement" funds (limited to 30% of total, with no council input). The bill establishes an Advisory Council to review grant applications and recommend funding to the legislature, while creating the Mississippi Opioid Response Center of Excellence (MSORCE) under the Mississippi Public Health Institute to coordinate statewide opioid treatment efforts and evaluation. These changes directly affect state agencies handling settlement funds, including the Attorney General’s office, public health departments, and local grant recipients.